Category: General

Eur J Cardiothorac Surg. 2024 Mar 1;65(3):ezae027. doi: 10.1093/ejcts/ezae027.

ABSTRACT

OBJECTIVES: The goal of this histological study was to assess the biocompatibility of vascular patches used in the repair of congenital heart defects.

METHODS: We examined tissue-engineered bovine (n = 7) and equine (n = 7) patches and autologous human pericardium (n = 7), all explanted due to functional issues or follow-up procedures. Techniques like Movat-Verhoeff, von Kossa and immunohistochemical staining were used to analyse tissue composition, detect calcifications and identify immune cells. A semi-quantitative scoring system was implemented to evaluate the biocompatibility aspects, thrombus formation, extent of pannus, inflammation of pannus, cellular response to patch material, patch degradation, calcification and neoadventitial inflammation.

RESULTS: We observed distinct material degradation patterns among types of patches. Bovine patches showed collagen disintegration and exudate accumulation, whereas equine patches displayed edematous swelling and material dissolution. Biocompatibility scores were lower in terms of cellular response, degradation and overall score for human autologous pericardial patches compared to tissue-engineered types. The extent of pannus formation was not influenced by the type of patch. Bovine patches had notable calcifications causing tissue hardening, and foreign body giant cells were more frequently seen in equine patches. Plasma cells were frequently detected in the neointimal tissue of engineered patches.

CONCLUSIONS: Our results confirm the superior biocompatibility of human autologous patches and highlight discernible variations in the changes of patch material and the cellular response to patch material between bovine and equine patches. Our approach implements the semi-quantitative scoring of various aspects of biocompatibility, facilitating a comparative quantitative analysis across all types of patches, despite their inherent differences.

PMID:38290761 | PMC:PMC10924714 | DOI:10.1093/ejcts/ezae027

J Biomech. 2024 Jan;163:111956. doi: 10.1016/j.jbiomech.2024.111956. Epub 2024 Jan 19.

ABSTRACT

This study aimed to investigate the hemodynamics of a novel fabric composite that can be used as a substitute for bovine pericardium. The structure is composed of ultrahigh molecular weight polyethylene (UHMWPE) fabric coated with thermoplastic polyurethane (TPU) membranes on both sides. In vitro experiments were carried out on two composite valve samples with different specifications and a bovine pericardial one with the same dimension and structure. Hemodynamic properties including the effective orifice area (EOA) and regurgitant fraction (RF) were obtained and compared through pulsatile-flow testing in a pulse duplicator. Using the particle image velocimetry (PIV) technique, frames of the downstream velocity field in the aortic valve chamber were captured during cardiac cycles. Then, the field of Reynolds shear stress (RSS), viscous shear stress (VSS), and turbulent kinetic energy (TKE) at peak systole were calculated. A fluid-structure interaction (FSI) model has also been used to verify the pulsatile-flow testing. Compared with the bovine pericardial valve, composite valves have nosuperiority regarding EOA and RF due to their slightly higher rigidity. However, shear stresses of composite valves were lower than those of the bovine pericardial valve indicating more stable blood flows, which means that composite leaflets have the potential to reduce the risks of thrombosis and hemolysis induced by the mechanical contact between the blood flow and leaflets of valve prostheses.

PMID:38266534 | DOI:10.1016/j.jbiomech.2024.111956

ASAIO J. 2024 Jan 3. doi: 10.1097/MAT.0000000000002130. Online ahead of print.

ABSTRACT

Pediatric patients who undergo surgery for long-segment congenital tracheal stenosis (LSCTS) have suboptimal outcomes and postsurgical complications. To address this, we propose a biosynthetic graft comprising (1) a porcine small intestinal submucosa extracellular matrix (SIS-ECM) patch for tracheal repair, and (2) a resorbable polymeric exostent for biomechanical support. The SIS-ECM patch was evaluated in vivo in an ovine trachea model over an 8 month period. Concurrently, the biosynthetic graft was evaluated in a benchtop lamb trachea model for biomechanical stability. In vivo results show that SIS-ECM performs better than bovine pericardium (control) by preventing granulation tissue/restenosis, restoring tracheal architecture, blood vessels, matrix components, pseudostratified columnar and stratified epithelium, ciliary structures, mucin production, and goblet cells. In vitro tests show that the biosynthetic graft can provide the desired axial and flexural stability, and biomechanical function approaching that of native trachea. These results encourage future studies to evaluate safety and efficacy, including biomechanics and collapse risk, biodegradation, and in vivo response enabling a stable long-term tracheal repair option for pediatric patients with LSCTS and other tracheal defects.

PMID:38170278 | DOI:10.1097/MAT.0000000000002130